NYSE · Healthcare
UNITEDHEALTH GROUP INC (UNH)
As-reported financials and recent SEC filings for UNITEDHEALTH GROUP INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$447.57B
Net income
$12.06B
Net margin
2.7%
Diluted EPS
$13.23
ROE
12.0%
P/E (TTM)
30.8×
Market cap
$371.00B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B |
| Gross profit | — | — | — | — | $256.56B |
| Operating income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B |
| Net income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B |
| Diluted EPS | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-05
View on EDGAR →42026-06-04
View on EDGAR →42026-06-04
View on EDGAR →DEFA14A2026-05-15
View on EDGAR →8-K2026-05-11
View on EDGAR →10-Q2026-05-05
View on EDGAR →SCHEDULE 13G2026-04-30
View on EDGAR →42026-04-27
View on EDGAR →Go deeper on UNH
Search UNITEDHEALTH GROUP INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.